An in-depth look to ENORAMA PHARMA AB operating, investing, and financing activities

ERMA free cash flow for Q3 24 is -9.79 M SEK. For 2023, ERMA free cash flow was -41.35 M SEK and operating cash flow was -41.35 M SEK.